Byotrol Plc Distribution Agreements Signed for ...

Byotrol plc
                  The Directors of Byotrol plc (the 'Company') are pleased to announce that the
Company has entered into two separate distribution agreements with SunChoice
Europe Limited ('SunChoice') and DBM Holdings Ltd ('DBM') to supply Byotrol's
assure product range into the UK care homes market.

SunChoice distributes an extensive range of over 5000 products to more than
1,000 nursing and residential care homes in the UK. The product range includes
cleaning and janitorial products, medical consumables, uniforms and patient
handling equipment. SunChoice is wholly owned by Southern Cross Healthcare Group
plc, the largest provider of care homes and long term care beds in the UK, which
operates over 570 care homes, providing more than 28,000 beds and employing
around 33,000 staff.

Based in Edinburgh, DBM supplies products to healthcare and retail markets, with
a particular focus on independent care home operators throughout the UK.

Byotrol's assure range has been specifically developed for the care homes sector
and comprises disinfectant sprays for use in living areas, kitchens and
bathrooms, cleaning and sanitising wipes, and a hand sanitising mousse. The
Company's patented technology has been proven, through extensive testing, to be
effective in eradicating and controlling a wide range of organisms such as MRSA,
c.difficile and e-coli. Byotrol remains active after it has dried, providing
anti-microbial protection for extended periods after application and is able
therefore to tackle the practical problems of odours and spoilage caused by
microbe activity.

Byotrol is not toxic to humans and does not require any specialist equipment or
alteration to existing cleaning regimens to be effective. A further advantage of
Byotrol is also its ultra low alcohol content, compared to competing products,
which means it does not dry or irritate the skin when used as a hand sanitiser
as part of infection control procedures.

The Directors anticipate that the agreements with SunChoice and DBM will make a
significant contribution to the Company's future revenues.

Stephen Falder, Byotrol's Deputy Chairman commented:

'We are delighted to be working with SunChoice and DBM, who will be marketing
our assure product range to a significant number of nursing and residential care
homes in the UK. Byotrol has undergone extensive testing and has been shown to
deliver substantial benefits to both residents and healthcare professionals .'

Barbara Hornby, Managing Director for SunChoice Europe commented:

'Working with Byotrol is a significant move for SunChoice Europe to provide a
leading edge, yet proven solution for infection control. We now have the
opportunity to distribute this innovative technology to care homes across the
UK, helping to combat the risk and spread of MRSA and other harmful
micro-organisms.'

Gary Walsh, Marketing Director for DBM stated:

'The partnership with Byotrol enables DBM to provide truly innovative control
methods which are safe to use, compatible with the material they protect and
also comply with increasingly strict regulatory controls. This ground breaking
anti microbial technology will provide care and nursing homes with a truly
unique method of combating the risk and spread of MRSA and other harmful
micro-organisms in higher risk environments. We also believe that the results of
the recent study at Glasgow Royal Infirmary will have a positive impact on
potential customers.'

26 October 2006

Enquiries:

-0-
*T
Byotrol plc                          0161 277 9518

Stephen Falder
Deputy Chairman

David McRobbie
Chief Executive
Charles Stanley Securities           020 7149 6457

Philip Davies
First City PR                        0207 436 7486

Allan Piper
McCann Erickson PR                   01625 822540

Jim Rothnie
*T